REGENERON PHARMACEUTICALS, INC. reports

Company location: Tarrytown, NY
Fiscal year end: 31 December

REGENERON PHARMACEUTICALS, INC. has filed 2,462 SEC EDGAR filings since 26 Jul 1995

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 526-550 of 1,000 matching filings.

Per page

25

Current page

22

4

PRIMARY DOCUMENT

Filing date: 23 Mar 2022
Reporting date: 21 Mar 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 23 Mar 2022
Reporting date: 21 Mar 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 18 Mar 2022
Reporting date: 16 Mar 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 18 Mar 2022
Reporting date: 16 Mar 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 18 Mar 2022
Reporting date: 16 Mar 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 15 Mar 2022
Reporting date: 14 Mar 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-19034

FORM 8-K

Filing date: 08 Mar 2022
Reporting date: 02 Mar 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 03 Mar 2022
Reporting date: 01 Mar 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 03 Mar 2022
Reporting date: 01 Mar 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 01 Mar 2022
Reporting date: 25 Feb 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 24 Feb 2022
Reporting date: 22 Feb 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 24 Feb 2022
Reporting date: 23 Feb 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 16 Feb 2022
Reporting date: 14 Feb 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

SCHEDULE 13G/A

Filing date: 11 Feb 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

SCHEDULE 13G/A

Filing date: 11 Feb 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G

SCHEDULE 13G

Filing date: 11 Feb 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-41938

SEC SCHEDULE 13G

Filing date: 11 Feb 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-41938

SCHEDULE 13G/A

Filing date: 10 Feb 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-41938

SC 13G/A filing

Filing date: 09 Feb 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

10-K File 000-19034

10-K

Filing date: 07 Feb 2022
Reporting date: 31 Dec 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 000-19034

8-K

Filing date: 04 Feb 2022
Reporting date: 04 Feb 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 02 Feb 2022
Reporting date: 01 Feb 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 02 Feb 2022
Reporting date: 01 Feb 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-41938

SC 13G/A filing

Filing date: 01 Feb 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-19034

FORM 8-K

Filing date: 10 Jan 2022
Reporting date: 10 Jan 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .